Development of our R&D strategy

In 2011, we laid the foundations for the Belgian Red Cross-Flanders research and development strategy. In 2012, we further developed that strategy and put it into practice. In putting the R&D strategy into practice, maximum account was taken of our expertise in validations and that of the Centre for Evidence-Based Practice. We also invested in further developing high-tech methods at the Transfusion Research Center (TReC).

As regards the Blood Service, we are focusing on two lines of research, into donors and blood components respectively. Within these  pillars we are working at a number of levels: operational, development-oriented and basic translational research. It is this layered approach which gives our R&D strategy its strength.

Type A research is geared towards operational and quality improvements. Example:  How can we improve what we are already doing today?

Type B research is development work. Here we use existing knowledge to develop or test out new processes. Example: How can we achieve better informed donor selection, or better blood products? 

Type C comprises basic and translational research. Basic research involves amassing as much knowledge as possible about core principles. Example: How do platelets behave during a production process? What does this mean in physiological terms?

In translational research, basic knowledge is put to practical use in the field of research. How can information about the properties of platelets, for example, be used in therapy?

Related items:

Overview of research and studies carried out in 2012

Continuous training

BI support tool